Patents by Inventor Eric Postel

Eric Postel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8088587
    Abstract: Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness in the elderly whose etiology remains largely unknown. Previous studies identified chromosome 1q32 as harboring a susceptibility locus for AMD, but it was not identified. We identified a strongly associated haplotype in two independent data sets. DNA sequencing of the complement factor II gene (CFII) within this haplotype revealed a coding variant, Y402II, that significantly increases the risk for AMD with odds ratios between 2.45 and 5.57. This identifies Complement factor II as involved in pathogenesis of AMD. This single variant alone is so common that it likely explains 43 percent of AMD in older adults. In addition, we have replicated and refined previous reports implicating a coding change in LOC387715 as the second major AMD susceptibility allele. The effect of rs10490924 appears to be completely independent of the Y402H variant in the CFH gene.
    Type: Grant
    Filed: March 6, 2006
    Date of Patent: January 3, 2012
    Assignees: Vanderbilt University, Duke University
    Inventors: Margaret A. Pericak-Vance, Jonathan L. Haines, Eric Postel, Anita Agarwal, Michael A. Hauser, Silke Schmidt, William K. Scott
  • Publication number: 20100190264
    Abstract: Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness in the elderly whose etiology remains largely unknown. Previous studies identified chromosome 1q32 as harboring a susceptibility locus for AMD, but it was not identified. We identified a strongly associated haplotype in two independent data sets. DNA sequencing of the complement factor II gene (CHI) within this haplotype revealed a coding variant, Y402II, that significantly increases the risk for AMD with odds ratios between 2.45 and 5.57. This identifies Complement factor II as involved in pathogenesis of AMD. This single variant alone is so common that it likely explains 43 percent of AMD in older adults. In addition, we have replicated and refined previous reports implicating a coding change in LOC387715 as the second major AMD susceptibility allele. The effect of rs10490924 appears to be completely independent of the Y402II variant in the CFH gene.
    Type: Application
    Filed: March 6, 2006
    Publication date: July 29, 2010
    Applicants: VANDERBILT UNIVERSITY MEDICAL CENTER, OFFICE OF TECHNOLOGY TRANSFER AND ENTERPRISE DEVELOPMENT, DUKE UNIVERSITY
    Inventors: Margaret A. Pericak-Vance, Jonathan L. Haines, Eric Postel, Anita Agarwal, Michael A. Hauser, Silke Schmidt, William K. Scott